Free Trial

Evolent Health (EVH) Stock Price, News & Analysis

Evolent Health logo
$9.40 -0.29 (-2.94%)
As of 01:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Evolent Health Stock (NYSE:EVH)

Key Stats

Today's Range
$9.38
$9.82
50-Day Range
$8.58
$11.22
52-Week Range
$8.35
$33.63
Volume
393,648 shs
Average Volume
2.12 million shs
Market Capitalization
$1.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.71
Consensus Rating
Buy

Company Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Remove Ads

Evolent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

EVH MarketRank™: 

Evolent Health scored higher than 53% of companies evaluated by MarketBeat, and ranked 396th out of 655 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Evolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Evolent Health has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Evolent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Evolent Health are expected to decrease in the coming year, from $0.08 to ($0.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evolent Health is -11.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evolent Health is -11.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Evolent Health has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Evolent Health's valuation and earnings.
  • Percentage of Shares Shorted

    12.38% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Evolent Health has recently increased by 15.17%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Evolent Health does not currently pay a dividend.

  • Dividend Growth

    Evolent Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.38% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Evolent Health has recently increased by 15.17%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Evolent Health has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Evolent Health this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Evolent Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $666,315.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of Evolent Health is held by insiders.

  • Read more about Evolent Health's insider trading history.
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Stock News Headlines

This Crypto Is Set to Explode in February
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
Evolent Health price target lowered to $12 from $13 at JPMorgan
See More Headlines

EVH Stock Analysis - Frequently Asked Questions

Evolent Health's stock was trading at $11.25 on January 1st, 2025. Since then, EVH shares have decreased by 15.5% and is now trading at $9.5050.
View the best growth stocks for 2025 here
.

Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings results on Thursday, February, 20th. The technology company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.38 by $0.35. The technology company earned $646.54 million during the quarter, compared to analysts' expectations of $650.92 million. Evolent Health had a negative net margin of 2.41% and a positive trailing twelve-month return on equity of 5.73%.

Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Top institutional investors of Evolent Health include Vanguard Group Inc. (9.58%), Wellington Management Group LLP (8.95%), Engaged Capital LLC (4.64%) and Cadian Capital Management LP (4.48%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty, Cheryl Scott, Mary Bridget Duffy and Brendan B Springstubb.
View institutional ownership trends
.

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
2/20/2025
Today
3/25/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Management services
Sub-Industry
Business Services
Current Symbol
NYSE:EVH
Employees
5,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.71
High Stock Price Target
$35.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+82.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
121.09
P/E Growth
N/A
Net Income
$-113,040,000.00
Pretax Margin
-3.54%

Debt

Sales & Book Value

Annual Sales
$2.55 billion
Cash Flow
$1.61 per share
Price / Cash Flow
6.00
Book Value
$9.38 per share
Price / Book
1.03

Miscellaneous

Free Float
114,699,000
Market Cap
$1.13 billion
Optionable
Optionable
Beta
1.49

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:EVH) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners